Abstract
The Elizabethkingia are a genetically diverse genus of emerging pathogens that exhibit multidrug resistance to a range of common antibiotics. Two representative species, Elizabethkingia bruuniana and E. meningoseptica, were phenotypically tested to determine minimum inhibitory concentrations (MICs) for five antibiotics. Ultra-long read sequencing with Oxford Nanopore Technologies (ONT) and subsequent de novo assembly produced complete, gapless circular genomes for each strain. Alignment based annotation with Prokka identified 5,480 features in E. bruuniana and 5,203 features in E. meningoseptica, where none of these identified genes or gene combinations corresponded to observed phenotypic resistance values. Pan-genomic analysis, performed with an additional 19 Elizabethkingia strains, identified a core-genome size of 2,658,537 bp, 32 uniquely identifiable intrinsic chromosomal antibiotic resistance core-genes and 77 antibiotic resistance pan-genes. Using core-SNPs and pan-genes in combination with six machine learning (ML) algorithms, binary classification of clindamycin and vancomycin resistance achieved f1 scores of 0.94 and 0.84, respectively. Performance on the more challenging multiclass problem for fusidic acid, rifampin and ciprofloxacin resulted in f1 scores of 0.70, 0.75, and 0.54, respectively. By producing two sets of quality biological predictors, pan-genome genes and core-genome SNPs, from long-read sequence data and applying an ensemble of ML techniques, our results demonstrated that accurate phenotypic inference, at multiple AMR resolutions, can be achieved.
Highlights
Emerging antimicrobial resistance (AMR) is a global crisis
We inspected the predictability of AMR using six ML algorithms, and the results suggest a promising ML-based approach for the prediction of binary AMR classification
Based on our results, one set of predictors may prove effective at AMR prediction than other predictor sets for a particular phenotype
Summary
Emerging antimicrobial resistance (AMR) is a global crisis. A recent report has predicted that by 2050 antimicrobial resistance will lead to 10 million deaths annually and cost the world’s economy upward of $100 trillion (O’Neill, 2016; Tacconelli and Magrini, 2017). MICs quantify how susceptible, or resistant, a cultured strain is to selected antimicrobial drugs by observing the visible growth of the bacterium under antibiotic stress (Jorgensen and Ferraro, 2009). These protocols, are time-consuming and the interpretation of susceptibility for many antimicrobial/pathogen combinations have not yet been standardized (Horne et al, 2013). These procedures rely on the successful growth of bacterial isolates, making them incompatible with “unculturable” bacteria (Vartoukian et al, 2010). Full spectrum AMR detection remains challenging (Chitsaz et al, 2011)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.